These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39056197)

  • 1. Towards eliminating hepatitis C as a public health threat: different speeds, different needs.
    Matičič M; Buti M
    Euro Surveill; 2024 Jul; 29(30):. PubMed ID: 39056197
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
    Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
    Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gender lens is needed in hepatitis C elimination research.
    Larney S; Madden A; Marshall AD; Martin NK; Treloar C
    Int J Drug Policy; 2022 May; 103():103654. PubMed ID: 35306279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
    Duffell EF; Hedrich D; Mardh O; Mozalevskis A
    Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards elimination goals for viral hepatitis.
    Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
    Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies.
    Mousavi S; Alavi M; Delavari A; Poustchi H; Mohammadi Z; Malekzadeh R
    J Viral Hepat; 2024 Sep; 31(9):565-572. PubMed ID: 38831601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.
    Scott N; Wilson DP; Thompson AJ; Barnes E; El-Sayed M; Benzaken AS; Drummer HE; Hellard ME
    BMC Med; 2019 Sep; 17(1):175. PubMed ID: 31530275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
    Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
    J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Second Biggest Infectious Disease Killer in the U.S.: Hepatitis C Virus Infection and Steps Towards its Elimination in Rhode Island and Beyond.
    Taylor LE
    R I Med J (2013); 2020 Jun; 103(5):19-21. PubMed ID: 32481774
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 14. Australia needs to increase testing to achieve hepatitis C elimination.
    Scott N; Sacks-Davis R; Wade AJ; Stoove M; Pedrana A; Doyle JS; Thompson AJ; Wilson DP; Hellard ME
    Med J Aust; 2020 May; 212(8):365-370. PubMed ID: 32167586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons Learned From Global Hepatitis C Elimination Programs.
    Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
    J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US Veterans Health Administration Hepatitis C Virus (HCV) Program: A Model for National HCV Elimination Through Patient-Centered Medical Homes.
    Litwin AH; Akiyama MJ
    Clin Infect Dis; 2024 Jun; 78(6):1580-1582. PubMed ID: 38279941
    [No Abstract]   [Full Text] [Related]  

  • 17. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public Health Approaches Toward Eliminating Hepatitis C Virus in Rhode Island.
    Murphy M; Howe K; Marak T; Bertrand T; Maynard M; Ndoye CD; Joseph R; Fingerut J; Chan PA
    R I Med J (2013); 2020 Jun; 103(5):22-25. PubMed ID: 32481775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliminating hepatitis C: The importance of frequent testing of people who inject drugs in high-prevalence settings.
    Scott N; Sacks-Davis R; Pedrana A; Doyle J; Thompson A; Hellard M
    J Viral Hepat; 2018 Dec; 25(12):1472-1480. PubMed ID: 30047625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
    Lazarus JV; Safreed-Harmon K; Thursz MR; Dillon JF; El-Sayed MH; Elsharkawy AM; Hatzakis A; Jadoul M; Prestileo T; Razavi H; Rockstroh JK; Wiktor SZ; Colombo M
    Semin Liver Dis; 2018 Aug; 38(3):181-192. PubMed ID: 29986353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.